Sarepta Therapeutics SRPT announced that the FDA has granted platform-technology designation to its viral vector rAAVrh74, used in the investigational gene therapy SRP-9003. This therapy is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback